Authors: FJORDSIDE L JEPPESEN U EAP CP POWELL K BAUMANN P BROSEN K

Citation: L. Fjordside et al., THE STEREOSELECTIVE METABOLISM OF FLUOXETINE IN POOR AND EXTENSIVE METABOLIZERS OF SPARTEINE, Nordic journal of psychiatry, 52(2), 1998, pp. 113-114

Authors: RASMUSSEN BB JEPPESEN U GAIST D BROSEN K

Citation: Bb. Rasmussen et al., GRISEOFULVIN AND FLUVOXAMINE INTERACTIONS WITH THE METABOLISM OF THEOPHYLLINE, Therapeutic drug monitoring, 19(1), 1997, pp. 56-62

Authors: JEPPESEN U RASMUSSEN JM BROSEN K

Citation: U. Jeppesen et al., CLINICALLY IMPORTANT INTERACTION BETWEEN AZATHIOPRINE (IMUREL) AND PHENPROCOUMON (MARCOUMAR), European Journal of Clinical Pharmacology, 52(6), 1997, pp. 503-504

Authors: JEPPESEN U RASMUSSEN BB BROSEN K

Citation: U. Jeppesen et al., FLUVOXAMINE INHIBITS THE CYP2C19-CATALYZED BIOACTIVATION OF CHLOROGUANIDE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 279-286

Authors: JEPPESEN U LOFT S POULSEN HE BROSEN K

Citation: U. Jeppesen et al., A FLUVOXAMINE-CAFFEINE INTERACTION STUDY, Pharmacogenetics, 6(3), 1996, pp. 213-222

Authors: JEPPESEN U GRAM LF VISTISEN K LOFT S POULSEN HE BROSEN K

Citation: U. Jeppesen et al., DOSE-DEPENDENT INHIBITION OF CYP1A2, CYP2C19 AND CYP2D6 BY CITALOPRAM, FLUOXETINE, FLUVOXAMINE AND PAROXETINE, European Journal of Clinical Pharmacology, 51(1), 1996, pp. 73-78